N,N,N-三甲基-2-[(2-甲基-1-氧代-2-丙基)氧]-乙氨甲基硫酸酯 | 6891-44-7

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N,N,N-三甲基-2-[(2-甲基-1-氧代-2-丙基)氧]-乙氨甲基硫酸酯
• 中文别名: [2-(甲基丙烯酸)乙基]三甲胺甲基硫酸盐；甲基丙烯酰氧乙基三甲基铵甲基硫酸盐
• 英文名称: 2-(N,N,N-trimethylammonio)ethyl methacrylate methyl sulfate
• 英文别名: N,N,N-trimethylammonioethyl methacrylate methyl sulfate；N,N,N-trimethyl-N-(2-(methacryloyloxy)ethyl)ammonium methyl sulfate；(2-(Methacryloyloxy)ethyl)trimethylammonium methyl sulfate；methyl sulfate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium
• CAS: 6891-44-7
• 化学式: CH₃O₄S*C₉H₁₈NO₂
• 分子量: 283.346
• InChiKey: IHBKAGRPNRKYAO-UHFFFAOYSA-M

物化性质

• 沸点：
  170℃ at 98.3kPa
• 密度：
  1.183 g/mL at 25 °C
• LogP：
  -4 at 20℃ and pH7
• 物理描述：
  Liquid

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  101
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R38

反应信息

• 作为反应物：
  描述：

  bis(acetylacetonato)nitratomanganese(III) 、 N,N,N-三甲基-2-[(2-甲基-1-氧代-2-丙基)氧]-乙氨甲基硫酸酯 生成
  参考文献：
  名称：

  摘要：

  The kinetic features of initiation of N,N,N-trimethylammonioethyl methacrylate methyl sulfate polymerization in the presence of manganese(III) bis(acetylacetonate) nitrate and p-nitrosoaniline were studied by the inhibited polymerization method. The kinetic parameters of initiation were calculated, and participation of the monomer in the initiation stage was established.

  DOI：

  10.1023/a:1013786025311
• 作为产物：
  描述：

  甲基丙烯酸二甲氨乙酯 、 硫酸二甲酯 以 异丙醇 为溶剂， 反应 6.0h， 生成 N,N,N-三甲基-2-[(2-甲基-1-氧代-2-丙基)氧]-乙氨甲基硫酸酯
  参考文献：
  名称：

  顔料分散剤

  摘要：

  本发明旨在提供一种能够获得在水性介质中具有优异颜料分散性的水性墨水，当将该墨水印刷在纸张上时，能够使颜料与纸张表面一起吸附并获得高浓度印刷的颜料分散剂。该颜料分散剂包含具有由下述一般式（1）表示的构成单位（a）和其他乙烯性不饱和单量体（B）组成的构成单位（b）的共聚物（C）。【化1】[式中，R1代表氢原子或甲基基，R2和R3分别独立表示碳数为1~24的烷基基，R4表示氢原子、碳数为1~24的烷基基或芳基，X表示阴离子原子或阴离子基，n表示1~10的整数。]【选择图】无

  公开号：

  JP2015063626A

文献信息

• [EN] FORCE-RESPONSIVE POLYMERSOMES AND NANOREACTORS; PROCESSES UTILIZING THE SAME<br/>[FR] POLYMERSOMES ET NANORÉACTEURS SENSIBLES À LA FORCE; PROCÉDÉS LES UTILISANT
  申请人：ADOLPHE MERKLE INSTITUTE UNIV OF FRIBOURG

  公开号：WO2019034597A1

  公开（公告）日：2019-02-21

  The mechanically induced melting properties of DNA were employed to achieve force labile membranes is described. Nucleobase pairs were used as mechanophores. Adenine and thymine functionalized complementary amphiphilic block copolymers were self-assembled into polymersomes. The nucleobases formed hydrogen bonds which were disrupted upon force stimulation. The exposure of the disconnected nucleobases to the hydrophobic matrix of the membranes lead to a change of permeability which permitted the exchange of water-soluble molecules throughout the polymer matrix. Moreover, the encapsulation of horseradish peroxidase enabled the reaction of luminol with hydrogen peroxide to yield a luminescence producing species similar to the marine bioluminescence. Moreover, the same nano-reactors were employed to catalyze the formation of a polyacrylamide gel when force was applied. Insights into the change of permeability of supramolecular networks upon force are provided. These systems are useful for drug delivery, as nanoreactors and for the selective release of curing agents for 3D printing, or fragrances.

  DNA的机械诱导熔化特性被用来实现易受力破裂的膜。核碱基对被用作机械感受器。腺嘌呤和胸腺嘧啶功能化的互补两性分块共聚物自组装成聚合体囊。核碱基形成氢键，在受力刺激下被破坏。断开的核碱基暴露在膜的疏水基质中，导致渗透性的改变，从而允许水溶性分子在聚合物基质中交换。此外，封装辣根过氧化物酶使得辣根酰胺与过氧化氢反应产生类似海洋生物发光的发光物种。此外，当施加力时，相同的纳米反应器被用来催化聚丙烯酰胺凝胶的形成。提供了关于受力下超分子网络渗透性变化的见解。这些系统可用于药物传递、纳米反应器以及用于3D打印的固化剂或香料的选择性释放。
• [EN] MACROMOLECULAR PRODRUGS FOR HARD TISSUE AND METHODS OF USE THEREOF<br/>[FR] PROMÉDICAMENTS MACROMOLÉCULAIRES POUR TISSU DUR ET LEURS PROCÉDÉS D'UTILISATION
  申请人：NEW YORK SOC RUPTURED & CRIPPLED MAINTAINING HOSPITAL FOR SPECIAL SURGERY

  公开号：WO2014036548A1

  公开（公告）日：2014-03-06

  Compositions for intravenous administration and methods for treating bone diseases, disorders, and fractures comprising macromolecular prodrugs of hydrophobic bone anabolic agents are provided. Specifically, novel macromolecular amphiphilic prodrugs wherein at least three molecules of simvastatin are conjugated to polyethylene glycol, which spontaneously form micelles in aqueous solutions are provided.

  提供用于静脉给药的组成物以及包括疏水性骨骼合成剂的巨分子前药治疗骨骼疾病、紊乱和骨折的方法。具体而言，提供新颖的巨分子两亲性前药，其中至少三分子辛伐他汀与聚乙二醇共轭，它们在水溶液中自发形成胶束。
• Process for preparing vinyl substituted beta-diketones
  申请人：Southard E. Glen

  公开号：US20060069288A1

  公开（公告）日：2006-03-30

  A process for preparing vinyl substituted beta-diketones includes reacting a halogen-containing beta-diketone with an olefin in a reaction zone under Heck coupling reaction conditions in the presence of a catalyst, a base, and an organic phosphine to provide a vinyl substituted beta-diketone product.

  制备乙烯基取代的β-二酮的方法包括在反应区域中，在存在催化剂、碱和有机膦的条件下，将含卤素的β-二酮与烯烃进行 Heck 偶联反应，从而得到乙烯基取代的β-二酮产物。
• Cosmetic composition based on a cosmetically active compound and a gel comprising at least one crosslinked network of crosslinked polymer particles
  申请人：Mathonneau Estelle

  公开号：US20050186165A1

  公开（公告）日：2005-08-25

  The present disclosure relates to a cosmetic composition, especially a hair composition, comprising, in a cosmetically acceptable medium, at least one cosmetically active compound and a gel comprising at least one crosslinked network of crosslinked polymer particles. The disclosure is also directed towards a method for fixing and/or holding a hairstyle using the composition, and also to the method of manufacturing a gel cosmetic formulation for holding and/or fixing the hairstyle.

  本公开涉及一种化妆品组合物，特别是一种头发组合物，包括至少一种化妆上可接受的介质中的至少一种化妆活性化合物和一种明胶，该明胶包括至少一种交联聚合物粒子的交联网络。该公开还涉及一种使用该组合物固定和/或保持发型的方法，以及制备用于保持和/或固定发型的明胶化妆配方的方法。
• RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY
  申请人：UNIVERSITY OF UTAH RESEARCH FOUNDATION

  公开号：US20160166693A1

  公开（公告）日：2016-06-16

  Described herein are anti-cancer compounds composed of a macromolecule comprising (1) at least one anti-cancer agent directly or indirectly bonded to the macromolecule and (2) at least one high Z element directly or indirectly bonded to the macromolecule that is capable of producing Auger electrons upon exposure to X-ray energy. When the compounds are exposed to low energy X-ray (e.g., kilo electron volts KeV) Auger electrons are produced by the high Z elements present in the compound. Because lower energy is required when compared to typical radiotherapy, which uses therapeutic X-ray energy in the million electron volt range (MeV), the subject experiences lower collateral damage when compared to radiation therapy. Additionally, the presence of the anti-cancer agent provides a second mechanism for killing cancer cells. Methods for making and using the anti-cancer compounds are also described herein.

  本文描述了一种抗癌化合物，由包括（1）至少一种直接或间接与大分子结合的抗癌药物和（2）至少一种直接或间接与大分子结合的高Z元素组成，该高Z元素在暴露于X射线能量时能够产生奥古尔电子。当这些化合物暴露于低能量X射线（例如，千电子伏特KeV）时，化合物中存在的高Z元素会产生奥古尔电子。与使用百万电子伏特范围内的治疗性X射线能量（MeV）的典型放射疗法相比，所需的能量更低，因此受试者在与放射疗法相比时经历较低的附带损伤。此外，抗癌药物的存在提供了杀死癌细胞的第二机制。本文还描述了制备和使用抗癌化合物的方法。